Mattia Galli

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 38

Top Venues

European heart journal. Cardiovascular pharmacotherapy

European heart journal

Thrombosis and haemostasis

Journal of clinical medicine

Università Cattolica del Sacro Cuore Sede di Roma

Università Cattolica del Sacro Cuore Sede di Roma (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università Cattolica del Sacro Cuore Sede di Roma Nov 01 2016

Italy

Medical doctor :: Cardiovascular and Thoracic Sciences,

Education History

Università Cattolica del Sacro Cuore Sede di Roma Nov 01 2016

Italy

PHD :: Cardiovascular and Thoracic Sciences

Publications

Mattia Galli, Felice Gragnano, Christiaan J M Vrints, Felicita Andreotti
2024 ESC Guidelines on Chronic Coronary Syndromes: What is New in Pharmacotherapy? European heart journal. Cardiovascular pharmacotherapy (2024)
Mattia Galli, Giovanni Occhipinti, Dominick J Angiolillo
Aspirin hypersensitivity and intolerance. European heart journal. Cardiovascular pharmacotherapy 10 (3) (2024)
Mattia Galli, Giovanni Occhipinti, Stefano Benenati, Renzo Laborante, Luis Ortega-Paz, Francesco Franchi, Domenico D'Amario, Roberto Nerla, Fausto Castriota, Giacomo Frati, Giuseppe Biondi-Zoccai, Sebastiano Sciarretta, Dominick J Angiolillo
Comparative effects of different antiplatelet strategies in carriers of CYP2C19 loss-of-function alleles: a network meta-analysis. European heart journal. Cardiovascular pharmacotherapy (2024)
Alessandra Ida Celia, Mattia Galli, Silvia Mancuso, Cristiano Alessandri, Giacomo Frati, Sebastiano Sciarretta, Fabrizio Conti
Antiphospholipid Syndrome: Insights into Molecular Mechanisms and Clinical Manifestations. Journal of clinical medicine 13 (14) (2024)
Mattia Galli, Giovanni Occhipinti, Dominick J Angiolillo
Aspirin hypersensitivity and intolerance. European heart journal. Cardiovascular pharmacotherapy (2024)
Mattia Galli, Renato Francesco Maria Scalise, Eliano Pio Navarese
De-escalation versus shortening of dual antiplatelet therapy. European heart journal. Cardiovascular pharmacotherapy 10 (4) (2024)
Alessandra Ida Celia, Mattia Galli, Silvia Mancuso, Cristiano Alessandri, Giacomo Frati, Sebastiano Sciarretta, Fabrizio Conti
Antiphospholipid Syndrome: Insights into Molecular Mechanisms and Clinical Manifestations. Journal of clinical medicine 13 (14) (2024)
Mattia Galli, Claudio Laudani, Giovanni Occhipinti, Marco Spagnolo, Felice Gragnano, Domenico D'Amario, Eliano Pio Navarese, Roxana Mehran, Marco Valgimigli, Davide Capodanno, Dominick J Angiolillo
P2Y12 Inhibitor Monotherapy After Short DAPT in Acute Coronary Syndrome: A Systematic Review and Meta-analysis. European heart journal. Cardiovascular pharmacotherapy (2024)
Alessandra Ida Celia, Mattia Galli, Silvia Mancuso, Cristiano Alessandri, Giacomo Frati, Sebastiano Sciarretta, Fabrizio Conti
Antiphospholipid Syndrome: Insights into Molecular Mechanisms and Clinical Manifestations. Journal of clinical medicine 13 (14) (2024)
Mattia Galli, Sergio Terracina, Eleonora Schiera, Massimo Mancone, Luigi Frati, Dominick J Angiolillo, Fabio M Pulcinelli
Interindividual variability in platelet reactivity among individuals with or without antiplatelet therapy: results from a large tertiary care hospital. Journal of thrombosis and thrombolysis (2024)
Mattia Galli, Renato Francesco Maria Scalise, Eliano Pio Navarese
De-escalation versus shortening of DAPT. European heart journal. Cardiovascular pharmacotherapy (2024)
Mattia Galli, Renzo Laborante, Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini, Domenico D'Amario, Davide Capodanno, Elena Tremoli, Charles Micheal Gibson, Roxana Mehran, Dominick J Angiolillo
Factor XI Inhibitors in Early Clinical Trials: A Meta-analysis. Thrombosis and haemostasis (2023)
Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini, Mattia Galli, Latonya Been, Ghussan Ghanem, Awss Shalhoub, Tiffany Ossi, Andrea Rivas, Xuan Zhou, Andres M Pineda Maldonado, Siva Suryadevara, Daniel Soffer, Martin M Zenni, Lisa K Jennings, Dominick J Angiolillo
Switching from dual antiplatelet therapy with aspirin plus a P2Y12 inhibitor to dual pathway inhibition with aspirin plus vascular-dose rivaroxaban. Thrombosis and haemostasis (2023)
Pierre Sabouret, Giuseppe Biondi Zoccai, Maciej Banach, Mattia Galli
Modulation and personalization of therapy after acute coronary syndromes: the road to precision. European heart journal (2023)
Andrea Zito, Mattia Galli, Giuseppe Biondi Zoccai, Antonio Abbate, Pamela S Douglas, Giuseppe Princi, Domenico D'Amario, Cristina Aurigemma, Enrico Romagnoli, Carlo Trani, Francesco Burzotta
Diagnostic Strategies for the Assessment of Suspected Stable Coronary Artery Disease : A Systematic Review and Meta-analysis. Annals of internal medicine (2023)
Domenico D'Amario, Daniele Rodolico, Agni Delvinioti, Renzo Laborante, Chiara Iacomini, Carlotta Masciocchi, Attilio Restivo, Giuseppe Ciliberti, Mattia Galli, Antonio Donato Paglianiti, Antonio Iaconelli, Andrea Zito, Jacopo Lenkowicz, Stefano Patarnello, Alfredo Cesario, Vincenzo Valentini, Filippo Crea
Eligibility for the 4 Pharmacological Pillars in Heart Failure With Reduced Ejection Fraction at Discharge. Journal of the American Heart Association (2023)
Mattia Galli, Felicita Andreotti, Pierre Sabouret, Felice Gragnano
2023 ESC Guidelines on ACS: what is new in antithrombotic therapy? European heart journal. Cardiovascular pharmacotherapy (2023)
Mattia Galli, Giuseppe Gargiulo, Stefano Benenati, Roxana Mehran, Dominick J Angiolillo
Bivalirudin plus a high-dose infusion versus Heparin in patients with acute coronary syndrome. European heart journal. Cardiovascular pharmacotherapy (2023)
Mattia Galli, Giuseppe Gargiulo, Stefano Benenati, Roxana Mehran, Dominick J Angiolillo
Bivalirudin plus a high-dose infusion versus Heparin in patients with acute coronary syndrome. European heart journal. Cardiovascular pharmacotherapy (2023)
Gabriele Carciotto, Renato Francesco Maria Scalise, Victoria Garcia-Ruiz, Mattia Galli, Emmanuele Soraci, Alberto Magliarditi, Lucio Teresi, Enrica Nasso, Scipione Carerj, Gianluca Di Bella, Antonio Micari, Giuseppe De Luca
Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based Review. Journal of clinical medicine 12 (22) (2023)
Mattia Galli, Dominick J Angiolillo
Efficacy and safety of lidocaine vs. opioid analgesics in acute coronary syndromes. European heart journal. Acute cardiovascular care 12 (1) (2023)
Gabriele Cortellini, Alberto Raiteri, Mattia Galli, Marzia Lotrionte, Fabio Piscaglia, Antonino Romano
Acetylsalicylic acid challenge or desensitization in sensitive patients with cardiovascular disease. Journal of thrombosis and thrombolysis (2023)
Mattia Galli, Renzo Laborante, Giovanni Occhipinti, Andea Zito, Luigi Spadafora, Giuseppe Biondi-Zoccai, Roberto Nerla, Fausto Castriota, Domenico D'Amario, Davide Capodanno, Young Hoon Jeong, Takeshi Kimura, Roxana Mehran, Dominick J Angiolillo
Impact of Ethnicity on Antiplatelet Treatment Regimens for Bleeding Reduction in Acute Coronary Syndromes: A Systematic Review and Pre-specified Subgroup Meta-analysis. European heart journal. Cardiovascular pharmacotherapy (2023)
Mattia Galli, Giuseppe Gargiulo, Stefano Benenati, Roxana Mehran, Dominick J Angiolillo
Bivalirudin plus a high-dose infusion versus Heparin in patients with acute coronary syndrome. European heart journal. Cardiovascular pharmacotherapy (2023)
Mattia Galli, Renzo Laborante, Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini, Domenico D'Amario, Davide Capodanno, Elena Tremoli, C Michael Gibson, Roxana Mehran, Dominick J Angiolillo
Factor XI inhibitors in early clinical trials: a meta-analysis. Thrombosis and haemostasis (2023)
Mattia Galli, Dominick J Angiolillo
How is pharmacogenetics changing clinical trial design for percutaneous coronary intervention? Expert review of clinical pharmacology (2023)
Mattia Galli, Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini, Dominick J Angiolillo
Precision medicine in interventional cardiology: implications for antiplatelet therapy in patients undergoing percutaneous coronary intervention. Pharmacogenomics 23 (13) (2022)
Mattia Galli, Francesco Franchi, Fabiana Rollini, Latonya Been, Patrick Abou Jaoude, Andrea Rivas, Xuan Zhou, Sida Jia, Naji Maaliki, Chang Hoon Lee, Andres M Pineda, Siva Suryadevara, Daniel Soffer, Martin M Zenni, Tobias Geisler, Lisa K Jennings, Theodore A Bass, Dominick J Angiolillo
Pharmacodynamic Profiles of Dual-Pathway Inhibition with or without Clopidogrel versus Dual Antiplatelet Therapy in Patients with Atherosclerotic Disease. Thrombosis and haemostasis 122 (8) (2022)
Mattia Galli, Francesco Franchi, Fabiana Rollini, Latonya Been, Patrick Abou Jaoude, Andrea Rivas, Xuan Zhou, Sida Jia, Naji Maaliki, Chang Hoon Lee, Andres M Pineda, Siva Suryadevara, Daniel Soffer, Martin M Zenni, Tobias Geisler, Lisa K Jennings, Theodore A Bass, Dominick J Angiolillo
Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapy. European heart journal. Cardiovascular pharmacotherapy 8 (7) (2022)
Mattia Galli, Francesco Franchi, Fabiana Rollini, Luis Ortega-Paz, Domenico D'Amario, Raffaele De Caterina, Roxana Mehran, C Michael Gibson, Dominick J Angiolillo
Dual pathway inhibition in patients with atherosclerotic disease: pharmacodynamic considerations and clinical implications. Expert review of clinical pharmacology (2022)
Mattia Galli, Felicita Andreotti, Domenico D'Amario, Thomas F Lüscher, Italo Porto
Double or triple antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention: not a matter of faith. European heart journal. Cardiovascular pharmacotherapy 7 (3) (2022)
Mattia Galli, Luis Ortega-Paz, Dominick J Angiolillo
Oral P2Y12 inhibiting therapy in patients with acute coronary syndrome: finding the sweet spot. European heart journal (2022)
Mattia Galli, Stefano Benenati, Francesco Franchi, Fabiana Rollini, Davide Capodanno, Giuseppe Biondi-Zoccai, Giovanni Maria Vescovo, Larisa H Cavallari, Behnood Bikdeli, Jurrien Ten Berg, Roxana Mehran, Charles Michael Gibson, Filippo Crea, Naveen L Pereira, Dirk Sibbing, Dominick J Angiolillo
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials. European heart journal 43 (10) (2022)
Mattia Galli, Giuseppe Gargiulo
Towards a personalized selection of antithrombotic agents in patients undergoing PCI: the role of clinical presentation in tools for risk assessment. Journal of thrombosis and thrombolysis (2021)
Mattia Galli, Dominick J Angiolillo
Non-opioid analgesics in patients undergoing percutaneous coronary intervention: hype or hope? European heart journal 42 (39) (2021)
Luis Ortega-Paz, Mattia Galli, Davide Capodanno, Francesco Franchi, Fabiana Rollini, Behnood Bikdeli, Roxana Mehran, Gilles Montalescot, C Michael Gibson, Renato D Lopes, Felicita Andreotti, Dominick J Angiolillo
Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials. European heart journal. Cardiovascular pharmacotherapy (2021)
Mattia Galli, Francesco Franchi, Fabiana Rollini, Larisa H Cavallari, Davide Capodanno, Filippo Crea, Dominick J Angiolillo
Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations. Expert review of clinical pharmacology 14 (8) (2021)
Mattia Galli, Davide Capodanno, Felicita Andreotti, Filippo Crea, Dominick J Angiolillo
Safety and efficacy of P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary interventions. Expert opinion on drug safety 20 (1) (2020)

Mattia Galli.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mattia Galli